MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer Research

MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).

SG-094 is a Potent TPC2 Inhibitor for HCC Reasearch

6RK73 is a Covalent Irreversible and Specific UCHL1 Inhibitor

PND-1186 is a Highly-Specific FAK Inhibitor and Induces Apoptosis

Lapatinib is a Potent Inhibitor of the ErbB-2 and EGFR Tyrosine Kinase Domains

Tiragolumab is An Immune Checkpoint Inhibitor Binding to T-cell Immunoglobulin and TIGIT

Triple-Negative Breast Cancer - Network of Cancer Research

Adagrasib (MRTX849), a Potent KRAS G12C Inhibitor for KRAS G12C-mutated Locally Advanced or Metastatic NSCLC Research

LCH-7749944 is a Potent PAK4 Inhibitor and Induces Apoptosis

RETRACTED ARTICLE: A new synthetic derivative of cryptotanshinone

BM-1074 is a Potent and Specific Bcl-2/Bcl-xL Inhibitor

Ganetespib (STA-9090) is a HSP90 Inhibitor